Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ifn-kappa (1 trial)
ifn-kinoid (2 trials)
isa-51 (2 trials)
tnf-kinoid (4 trials)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Crohn Disease (Phase 2)
Dermatomyositis (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Trials (7 total)
Trial APIs (4 total)